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The up side of a gas shortage
T
he key to building strong bones and healthy joints is oxygen scarcity in 
the developing embryo. As Provot et al. show on page 451, a protein 
activated by low oxygen levels orchestrates the formation of limb bones 
and joints. The work demonstrates that one function of the protein is spurring 
differentiation of cartilage-constructing chondrocytes.
An embryo acquires all of its oxygen via diffusion, and some parts of 
the body can run short. But instead of suffocating tender young cells, an 
oxygen shortage galvanizes them to differentiate. Low oxygen levels switch 
on a transcription factor called hypoxia-inducible-factor-1 (Hif-1). The 
researchers had previously shown that Hif-1 promotes growth and survival 
of chondrocytes, which sculpt a cartilage template that later fills with bone. 
Provot et al. wanted to determine whether the transcription factor spurs 
cells to specialize into chondrocytes.
The team knocked out one subunit of the protein, Hif-1α, only in limb 
bud mesenchyme of mice. This tissue, which spawns chondrocytes and 
other cell types, normally pumps out Hif-1α and is oxygen-starved. The 
modified mice were born with stumpy, malformed legs. As embryos, their 
limbs were slow to fashion cartilage, and differentiation of mesenchyme 
cells into chondrocytes was tardy. Moreover, large numbers of cells perished in the center of the animals’ forming bones.
Limb joints are also hypoxic, and the Hif-1α–deficient mice displayed defects such as abnormally fused bones in the paws 
and delayed joint formation. The flaws were more severe in the wrists and ankles, which have the lowest oxygen concentra-
tions. The findings establish that Hif-1 promotes chondrocyte differentiation and joint formation in response to hypoxia. The 
next step, the researchers say, is to pin down which pathways Hif-1 activates to produce these effects. 
When VEGF strays
U
nlike many signaling molecules that remain true 
to one receptor, vascular endothelial growth factor 
(VEGF) is a two-timer. As Ball et al. show on page 
489, VEGF also activates the receptor for the related plate-
let-derived growth factor (PDGF). VEGF is involved in ev-
erything from wound repair to cancer, and the study is the 
first to catch it being unfaithful.
By prodding vascular cells to travel and divide, VEGF 
sparks formation and growth of blood vessels. PDGF is similar 
structurally and functionally. But although the growth factors 
are evolutionarily related–and so are their receptors–nobody 
had previously shown any cross-reactions.
Ball et al. chanced on the discovery when they noticed 
that VEGF stimulated mesenchymal stem cells (MSCs) to 
migrate and proliferate. No surprise, except that MSCs lack 
VEGF receptors. The cells kept moving when dosed with 
antibodies that block the VEGF receptor. But they halted 
after treatment with antibodies against PDGF receptors. The 
researchers also found that VEGF promoted receptor 
phosphorylation, a sign of activation.
The researchers don’t yet know whether PDGF can latch 
onto VEGF receptors. Another mystery is under what 
conditions stimulating the PDGF receptor with VEGF, 
rather than its normal ligand, is advantageous. The growth 
factors might convey slightly different messages. To find 
out, scientists could determine whether the receptor’s 
responses to the two growth factors occur at the same speed 
and activate similar downstream pathways. 
Breaking actin 
to rebuild it
T
o keep moving, a crawling cell 
requires a continuous supply of 
actin molecules. As Kiuchi et al. 
show on page 465, coﬁ   lin meets 
this need mainly by snipping apart 
actin ﬁ  bers.
As a cell slithers, addition of 
new actin molecules to the actin ﬁ  -
bers at its leading edge nudges the 
membrane forward. Coﬁ   lin boosts the amount of available 
actin monomers in the cell. It depolymerizes actin ﬁ  bers, re-
moving individual molecules. It can also sever ﬁ  bers, leaving 
barbed ends for actin nucleation. Scientists weren’t sure which 
action was more important for actin polymerization and how 
much coﬁ  lin contributed to the actin pool.
By tracking ﬂ   uorescent actin, Kiuchi et al. determined 
that coﬁ  lin is responsible for more than half of the available 
monomers. Experiments with a coﬁ  lin mutant that couldn’t de-
polymerize actin and another that couldn’t clip it revealed that 
most of the free actin comes from severed ﬁ  bers.
Coﬁ  lin spurs ﬁ  bers at the cell’s margin to add monomers. 
That effect might occur either because coﬁ  lin hikes the amount of 
free actin or because it increases the number of barbed ends, 
which are sticky to the monomers. But actin injected into cells 
hooks onto the ﬁ  bers even if coﬁ  lin is blocked, ruling out the sec-
ond explanation. The results indicate that coﬁ  lin keeps the actin 
pool well-stocked mainly by dismembering existing ﬁ  bers. 
In a cell lacking coﬁ  lin, 
actin monomers (red) still 
hook onto actin ﬁ  bers at 
the cell margin.
A mouse’s wrist has distorted and abnormally fused 
bones when Hif-1𝗂 is absent.